Entecavir
AI463-111
Phase 3 small_molecule completed
Quick answer
Entecavir for Hepatitis B, Chronic is a Phase 3 program (small_molecule) at Bristol-Myers Squibb with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Bristol-Myers Squibb
- Indication
- Hepatitis B, Chronic
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed